OACC (Oaktree Acquisition III Life Sciences) Interest Coverage: No Debt ⁽¹⁾ (As of Mar. 2026) — 100% Below Median

What is Oaktree Acquisition III Life Sciences Interest Coverage?

Oaktree Acquisition III Life Sciences OACC -0.28% 15 Interest Coverage is No Debt ⁽¹⁾ as of Mar. 2026, which is 100% below its 10-year median of 10,000.00. GuruFocus rates OACC with a GF Score™ of 15/100. Among 389 Diversified Financial Services companies, Oaktree Acquisition III Life Sciences ranks better than 99.49% on this metric.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income by its Interest Expense. Oaktree Acquisition III Life Sciences's Operating Income for the three months ended in Mar. 2026 was $-0.46 Mil. Oaktree Acquisition III Life Sciences's Interest Expense for the three months ended in Mar. 2026 was $0.00 Mil. Oaktree Acquisition III Life Sciences has no debt. The higher the ratio, the stronger the company's financial strength is.

Good Sign:

Ben Graham prefers companies' interest coverage to be at least 5. Oaktree Acquisition Corp III Life Sciences has enough cash to cover all of its debt. Its financial situation is stable.

(1) Note: For Interest Coverage, "No debt" indicates no long-term debt. An indication of "No Debt" does not necessarily mean that the company has no long-term debt obligations; it could be due to missing data in the quarterly or annual report. Use caution when interpreting this information.

The historical rank and industry rank for Oaktree Acquisition III Life Sciences's Interest Coverage or its related term are showing as below:

OACC' s Interest Coverage Range Over the Past 10 Years
Min: No Debt Med: No Debt Max: No Debt
Current: No Debt

OACC's Interest Coverage is ranked better than
99.49% of 389 companies
in the Diversified Financial Services industry
Industry Median: No Debt vs OACC: No Debt

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Oaktree Acquisition III Life Sciences (NAS:OACC) Interest Coverage Explanation

Ben Graham requires that a company has a minimum interest coverage of 5 with the companies he invested. If the interest coverage is less than 2, the company is burdened by debt. Any business slow or recession may drag the company into a situation where it cannot pay the interest on its debt.

Interest Coverage is an important factor when GuruFocus ranks a company's overage Financial Strength .

Oaktree Acquisition III Life Sciences Interest Coverage Related Terms

Oaktree Acquisition III Life Sciences Interest Coverage Historical Data

* Premium members only.

The historical data trend for Oaktree Acquisition III Life Sciences's Interest Coverage can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Note: For Interest Coverage, "No debt" indicates no long-term debt. An indication of "No Debt" does not necessarily mean that the company has no long-term debt obligations; it could be due to missing data in the quarterly or annual report. Use caution when interpreting this information.

Oaktree Acquisition III Life Sciences Interest Coverage Chart

Oaktree Acquisition III Life Sciences Annual Data

Trend

Dec24

Dec25

Interest Coverage

No Debt

Oaktree Acquisition III Life Sciences Quarterly Data
	Sep24	Dec24	Mar25	Jun25	Sep25	Dec25	Mar26
Interest Coverage	Get a 7-Day Free Trial			No Debt	No Debt	No Debt	No Debt	No Debt

OACC vs RAAQ, FACT, PLMK: Interest Coverage Comparison

For the Shell Companies subindustry, Oaktree Acquisition III Life Sciences's Interest Coverage, along with its competitors' market caps and Interest Coverage data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Oaktree Acquisition III Life Sciences Interest Coverage vs Diversified Financial Services Industry

For the Diversified Financial Services industry and Financial Services sector, Oaktree Acquisition III Life Sciences's Interest Coverage distribution charts can be found below:

* The bar in red indicates where Oaktree Acquisition III Life Sciences's Interest Coverage falls into.

Save Embed

15GF Score

Oaktree Acquisition Corp III Life Sciences OACC

Interest Coverage is just one metric. See GF Score™, valuation, warning signs, and more.

View Full Analysis

Oaktree Acquisition III Life Sciences Interest Coverage Calculation

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income (EBIT) by its Interest Expense:

If Interest Expense is negative and Operating Income is positive, then

Interest Coverage

-1

Operating Income

Interest Expense

Else if Interest Expense is negative and Operating Income is negative, then

The company did not have earnings to cover the interest expense.

Else if Interest Expense is 0 and Long-Term Debt & Capital Lease Obligation is 0, then

The company had no debt ⁽¹⁾.

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Oaktree Acquisition III Life Sciences's Interest Coverage for the fiscal year that ended in Dec. 2025 is calculated as

Here, for the fiscal year that ended in Dec. 2025, Oaktree Acquisition III Life Sciences's Interest Expense was $0.00 Mil. Its Operating Income was $-1.20 Mil. And its Long-Term Debt & Capital Lease Obligation was $0.00 Mil.

Oaktree Acquisition III Life Sciences had no debt ⁽¹⁾.

Oaktree Acquisition III Life Sciences's Interest Coverage for the quarter that ended in Mar. 2026 is calculated as

Here, for the three months ended in Mar. 2026, Oaktree Acquisition III Life Sciences's Interest Expense was $0.00 Mil. Its Operating Income was $-0.46 Mil. And its Long-Term Debt & Capital Lease Obligation was $0.00 Mil.

Oaktree Acquisition III Life Sciences had no debt ⁽¹⁾.

The higher the ratio, the stronger the company's Financial Strength is.

Frequently Asked Questions Learn more about Interest Coverage →

What does a Interest Coverage of No Debt <sup>(1)</sup> mean?

Oaktree Acquisition III Life Sciences (OACC) has a Interest Coverage of No Debt ⁽¹⁾ as of Mar. 2026. Interest Coverage measures a company's capability to pay interest expenses on its debt. View historical data on Oaktree Acquisition III Life Sciences and its competitors. This is 100% below median its historical median of 10,000.00. Over the past decade, Oaktree Acquisition III Life Sciences' Interest Coverage has ranged from 10,000.00 to 10,000.00. According to the industry distribution chart, Oaktree Acquisition III Life Sciences ranks #2 out of 389 companies in the Diversified Financial Services industry, placing it in the top 0.5%.

Is Oaktree Acquisition III Life Sciences' Interest Coverage too high?

Oaktree Acquisition III Life Sciences' current Interest Coverage of No Debt ⁽¹⁾ is 100% below median its 10-year median of 10,000.00. Over the past 10 years, this metric has ranged from a low of 10,000.00 to a high of 10,000.00. Based on the distribution chart, Oaktree Acquisition III Life Sciences ranks #2 out of 389 companies in the Diversified Financial Services industry, which is in the top quartile — a strong position relative to peers. Overall, Oaktree Acquisition III Life Sciences has a GF Score™ of 15/100, reflecting its overall financial health beyond just this single metric.

How does Oaktree Acquisition III Life Sciences' Interest Coverage compare to RAAQ and FACT?

According to the Diversified Financial Services industry distribution chart, Oaktree Acquisition III Life Sciences ranks #2 out of 389 companies for Interest Coverage. This places Oaktree Acquisition III Life Sciences in the top 1% of its industry — outperforming the majority of peers. The industry median Interest Coverage is 10,000.00. Historically, Oaktree Acquisition III Life Sciences' own Interest Coverage has ranged from 10,000.00 to 10,000.00 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.

What is a good Interest Coverage for a Diversified Financial Services company?

The median Interest Coverage among Diversified Financial Services companies is 10,000.00, based on 389 companies in the industry. Companies in the top quartile (top 25%) have a Interest Coverage significantly above this median, while those in the bottom quartile fall well below. However, Interest Coverage should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.

What does a high Interest Coverage mean?

A high Interest Coverage can signal that a stock is expensive relative to its fundamentals. Interest Coverage measures a company's capability to pay interest expenses on its debt. View historical data on Oaktree Acquisition III Life Sciences and its competitors. For the Diversified Financial Services industry, the median Interest Coverage is 10,000.00 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Oaktree Acquisition III Life Sciences's current Interest Coverage is No Debt ⁽¹⁾, which is 100% below median its own 10-year median of 10,000.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.

Is Oaktree Acquisition III Life Sciences stock overvalued right now?

Oaktree Acquisition III Life Sciences (OACC) has a current Interest Coverage of No Debt ⁽¹⁾. The current Interest Coverage is No Debt ⁽¹⁾, which is 100% below median its 10-year median of 10,000.00. Oaktree Acquisition III Life Sciences' overall GF Score™ is 15/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.

How is Interest Coverage calculated?

Interest Coverage is calculated from a company's financial statements. For Oaktree Acquisition III Life Sciences (OACC), the current Interest Coverage is No Debt ⁽¹⁾ as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.